drugset / Trial / NCT01146457

The Optimal Dosage of Intrathecal Morphine for Peripartum Analgesia

NCT01146457 ↗

Terminated 83 enrolled Beth Israel Deaconess Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the ideal dosage of intrathecal morphine for intra and post partum analgesia, while minimizing the side effect profile.

Timeline

Start
2010-07
Primary completion
2015-01
Completion
2015-01

Outcome

Outcome not reported

Stopped: “Principal Investigator”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified 25 ug Intrathecal
Comparator Morphine Other / unclassified 50 ug Intrathecal
Comparator Morphine Other / unclassified 75 ug Intrathecal
Comparator Morphine Other / unclassified 100 ug Intrathecal

Indications

No indication recorded.